Alpha 2.0
Login Register
» Authors » Juan Sanchis Fores

Juan Sanchis Fores

Explore the profile of Juan Sanchis Fores including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 245
Followers 0
Related Specialties
Cardiology & Vascular Diseases
General Medicine
Endocrinology
Top 10 Co-Authors
Michal Kidawa
Luigi Vignali
Xacobe Flores Rios
Filippo Zilio
Francesco Versaci
Jose Moreu
Petr Kala
Miha Cercek
Gianluca Caiazzo
Alessandra Scoccia
Published In
Rev Esp Cardiol (Engl Ed)
J Clin Med
Med Clin (Barc)
Rev Esp Cardiol
Eur Heart J Open
Affiliations
Soon will be listed here.
Recent Articles
1.
Older women with non-ST-elevation acute coronary syndrome undergoing invasive or conservative management: an individual patient data meta-analysis
Rubino F, Pompei G, Mills G, Kotanidis C, Laudani C, Bendz B, et al.
Eur Heart J Open . 2024 Dec; 4(6):oeae093. PMID: 39698149
Aims: Women and older patients are underrepresented in randomized controlled trials (RCTs) investigating treatment strategies following acute coronary syndrome. This study aims to evaluate the benefit of invasive vs. conservative...
2.
Impact of diabetes on epicardial reperfusion and mortality in a contemporary STEMI population undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry
De Luca G, Algowhary M, Uguz B, Oliveira D, Ganyukov V, Zimbakov Z, et al.
Nutr Metab Cardiovasc Dis . 2024 Dec; :103763. PMID: 39638679
Background And Aim: Diabetes has been shown in last decades to be associated with a significantly higher mortality among patients with ST-segment elevation myocardial infarction (STEMI) treated with primary PCI...
3.
Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry
De Luca G, Nardin M, Algowhary M, Uguz B, Oliveira D, Ganyukov V, et al.
J Hypertens . 2024 Oct; 43(2):246-254. PMID: 39445586
Background: Hypertension is the most prevalent cardiovascular risk factor, with several detrimental effects on the cardiovascular system. Contrasting results have been reported so far on its prognostic role in patients...
4.
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry
De Luca G, Algowhary M, Uguz B, Oliveira D, Ganyukov V, Busljetik O, et al.
J Clin Med . 2023 Mar; 12(6). PMID: 36983119
Background: The constraints in the management of patients with ST-segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic have been suggested to have severely impacted mortality levels. The aim of...
5.
Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry
De Luca G, Manzo-Silberman S, Algowhary M, Uguz B, Oliveira D, Ganyukov V, et al.
J Clin Med . 2023 Feb; 12(3). PMID: 36769546
Background: Several reports have demonstrated the impact of the COVID-19 pandemic on the management and outcome of patients with ST-segment elevation myocardial infarction (STEMI). The aim of the current analysis...
6.
Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS-STEMI COVID-19 Registry
De Luca G, Algowhary M, Uguz B, Oliveira D, Ganyukov V, Zimbakov Z, et al.
J Clin Med . 2022 Nov; 11(22). PMID: 36431198
The so-called “smoking paradox”, conditioning lower mortality in smokers among STEMI patients, has seldom been addressed in the settings of modern primary PCI protocols. The ISACS−STEMI COVID-19 is a large-scale...
7.
SARS-CoV-2 Positivity, Stent Thrombosis, and 30-day Mortality in STEMI Patients Undergoing Mechanical Reperfusion
De Luca G, Algowhary M, Uguz B, Oliveira D, Ganyukov V, Zimbakov Z, et al.
Angiology . 2022 Oct; 74(10):987-996. PMID: 36222189
SARS-Cov-2 has been suggested to promote thrombotic complications and higher mortality. The aim of the present study was to evaluate the impact of SARS-CoV-2 positivity on in-hospital outcome and 30-day...
8.
Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry
De Luca G, Nardin M, Algowhary M, Uguz B, Oliveira D, Ganyukov V, et al.
Respir Res . 2022 Aug; 23(1):207. PMID: 35971173
Background: Chronic obstructive pulmonary disease (COPD) is projected to become the third cause of mortality worldwide. COPD shares several pathophysiological mechanisms with cardiovascular disease, especially atherosclerosis. However, no definite answers...
9.
Optimal surgical timing after post-infarction ventricular septal rupture
Sanchez Vega J, Alonso Salinas G, Vieitez Florez J, Sole A, Lopez de Sa E, Sanz-Ruiz R, et al.
Cardiol J . 2022 May; 29(5):773-781. PMID: 35578757
Background: Ventricular septal rupture (VSR) following acute myocardial infarction (AMI) is a dangerous condition. Surgical VSR closure is the definitive therapy, but there is controversy regarding the surgical timing and...
10.
Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic
De Luca G, Nardin M, Algowhary M, Uguz B, Oliveira D, Ganyukov V, et al.
Diabet Epidemiol Manag . 2022 Jan; 4:100022. PMID: 35072135
Background: During the coronavirus disease 2019 (COVID-19) pandemic, concerns have been arisen on the use of renin-angiotensin system inhibitors (RASI) due to the potentially increased expression of Angiotensin-converting-enzyme (ACE)2 and...